Carcinoma in situ and treatment options

International Urology and Nephrology

Volumn 28, Issue 1, 1996, Pages 33-42

  Erton, M ^a   Ilker, Y ^a   Akdas A ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; BROMOPIRIMINE; DOXORUBICIN; EPIRUBICIN; KEYHOLE LIMPET HEMOCYANIN; MITOMYCIN C; RECOMBINANT ALPHA2B INTERFERON; THIOTEPA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CARCINOMA IN SITU; CLINICAL ARTICLE; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY;

EID: 0029945342     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02550135     Document Type: Article

References (25)

1. Althausen, A. F., Prout, G. R., Daly, J. J : Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J. Urol., 116, 575 (1976).
2. Lum, B. L., Torti, F. M.: Therapeutic approaches including interferon to carcinoma in situ of the bladder. Cancer Treatment Rev., 12 (Suppl) 45 (1985).
3. Torti, F. M., Lum, B. L.: Superficial bladder cancer: Risk of recurrence and potential role for interferon therapy. Cancer, 59, 613 (1987).
4. Farrow, G. M., Utz, B. C., Rife, C. C : Clinical observations on 69 cases of in situ carcinoma of the urinary bladder. Cancer Res., 37, 2794 (1977).
5. Melamed, M. R., Voutsa, N. G., Grabstald, H.: Natural history and clinical behavior of in situ carcinoma of the human urinary bladder. Cancer, 17, 1533 (1964)
6. Eisenberg, R. B., Roth, R. B., Schweinsberg, M. H.: Bladder tumors and associated proliferative mucosal lesions. J. Urol., 84, 544 (1960).
7. Schade, R. O., Swinney, J : The association of urothelial atypism with neoplasia: Its importance in treatment and prognosis. J. Urol., 109, 619 (1973).
8. Soloway, M. S., Murphy, W., Rao, M. K., Cox, C.: Serial multiple-site biopsies in patients with bladder cancer J. Urol., 120, 57 (1978).
9. Farrow, G M., Utz, D C.: Observations on microinvasive transitional cell carcinoma of the urinary bladder. Clin. Oncol., 1, 609 (1982).
10. Utz, D. C., Hanash, K. A., Farrow, G. M.: The plight of the patient with carcinoma in situ of the bladder. J. Urol., 103, 160 (1970).
11. Weinstein, R. S., Miller, A. W., Pauli, B. U.: Carcinoma in situ: Comments on the pathobiology of a paradox. Urol. Clin. North. Am., 7, 523 (1980).
12. Utz, D. C., Zincke, H.: Carcinoma in situ of the urinary tract. Urol. Clin. North. Am., 11, 535 (1984).
13. Utz, D. C., Farrow, D. M : Management of carcinoma in situ of the bladder: A case of surgical management. Urol. Clin. North. Am., 7, 533 (1980).
14. Bowen, J. T.: Cutan. Dis. Syph., 30, 241 (1912). Cited in: Melicow, M. M., Hollowell, J. W. [17].
15. Jensener, M.: Arch. Dermatol. Syph., 134, 361 (1921).
16. Melicow, M. M.: Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy. J. Urol., 68, 261 (1952).
17. Melicow, M. M., Hollowell, J. W.: Intra-urothelial cancer: Carcinoma in situ, Bowen's disease of the urinary system: Discussion of 30 cases J. Urol., 68, 736 (1952).
18. Farrow, G. M : Pathologist's role in bladder cancer. Semin. Oncol., 6, 198 (1979).
19. Klein, F. A., Herr, H W , Sogani, T. C., Whitmore, W. F Jr., Melamed, M. R.: Detection and follow-up of carcinoma of the urinary bladder by flow cytometry. Cancer, 50, 389 (1982).
20. Althausen, A. F., Prout, G. R. Jr., Daly, J. J.: Noninvasive papillary carcinoma of the bladder associated with carcinoma in situ. J. Urol., 116, 575 (1976).
21. Prout, G. R. Jr., Koontz, W. W. Jr., Coombs, L. J., Hawkins, I. R., Friedel, G. H : Long term fate of 90 patients with superficial bladder cancer randomly assigned to receive or not receive thiotepa. J. Urol., 130, 677 (1983).
22. Kurth, K., Vijah, W. J. F., Kate, F. T., Bogdanowicz, J. F., Carpentier, P. J., van Reyswoud, I.: Phase 1/2 study of intravesical epirubicin in patients with carcinoma in situ of the bladder. J. Urol., 146, 1508 (1991).
23. Lamm, D. L., Blumensten, B. A., Crawford, E. D., Montie, J. E., Scardino, P., Grossman, B., Stanisic, T. H., Smith, J. Jr., Sullivan, J., Sarosdy, M. F., Grissman, J. D., Coltman, C. A.: A randomized trial of intravesical doxorubicin and immunotherapy with Bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. N. Engl. J. Med., 325, 1205 (1991).
24. Robinson, M. R. G., Richards, B., Adib, R., Akdaş, A., Rigby, C. C., Pugh, R. C. B.: Intravesical BCG in the management of cell tumors of the bladder: A toxicity study. Bladder Tumors and other Topics in Urological Oncology. Plenum Press Ltd., New York 1980.
25. Bretton, P. R., Herr, H. W., Whitmore, W. F. Jr., Badalament, R. A., Kimmel, M., Provet, J., Oettgen, H. F., Melamed, M. R., Fair, W. R.: Intravesical Bacillus Calmette-Guérin therapy for in situ transitional cell carcinoma involving the prostatic urethra. J. Urol., 141, 853 (1989).